Brand Name(s)
Hyrimoz™ (This drug is a biosimilar to Humira®)
Drug Class
Biologics
How taken
Injection under the skin (subcutaneous)
Used for
Moderate to severe Crohn's disease and ulcerative colitis
Recommendations for Pregnancy
Effects to fetus are unknown
Recommendations for Lactation
Present in breast milk; talk to your doctor
Medication indication
Indicated for the treatment of adults with moderately-to-severely active Crohn's disease and ulcerative colitis
Indicated for pediatric use
Yes
Most common side effects
Common side-effects include injection site reactions such as redness, rash, swelling, itching, pain, or bruising; upper respiratory infections (including sinus infections); headaches, rash, nausea. Rare side effects include lupus-like syndrome.
Other
Serious infections have included tuberculosis (TB) and infections caused by viruses, fungi. Lupus-like reactions, and liver problem are rare but have also been reported. Another rare risk is cancer known as hepatosplenic T-cell lymphoma.
Scroll right by clicking & dragging with your cursor or swiping with your finger.